Mohammed Aleskandarany
| Name | Mohammed Aleskandarany |
|---|---|
| Job title | Senior Lecturer in Biomedical Science (Histopathology) |
| Research institute | College of Science and Engineering |
| ORCID | https://orcid.org/0000-0001-5538-5946 |
Research outputs
SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
Alfarsi, L. H., Ansari, R. E., Erkan, B., Fakroun, A., Craze, M. L., Aleskandarany, M., Cheng, K. W., Ellis, I. O., Rakha, E. A. and Green, A. R. 2025. SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. Scientific Reports. 15 (2805), pp. 1-16. https://doi.org/10.1038/s41598-025-87292-1Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer
Aleskandarany, M. 2024. Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer. BJC Reports. pp. 1-10. https://doi.org/10.1038/s44276-024-00097-zGraphX-Net: A Graph Neural Network-Based Shapley Values for Predicting Breast Cancer Occurrence
Basaad, A., Basurra, S., Vakaj, E. and Aleskandarany, M. 2024. GraphX-Net: A Graph Neural Network-Based Shapley Values for Predicting Breast Cancer Occurrence. IEEE Access. 12, pp. 93993 - 94007. https://doi.org/https://doi.org/10.1109/ACCESS.2024.3424526Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
Althobiti, M., El-sharawy, K. A., Joseph, C., Aleskandarany, M., Toss, M. S., Green, A. R. and Rakha, E. A. 2021. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer. Breast Cancer Research and Treatment. 189 (3), pp. 621-630. https://doi.org/10.1007/s10549-021-06336-y165
total views of outputs46
total downloads of outputs111
views of outputs this month18
downloads of outputs this month